Brief: HBM Holdings Says Hbm1022 Receives Clearance From FDA Of United States
07/02/2023 24:13
Feb 7 (Reuters) - Hbm Holdings Ltd 2142.HK :
* FOOD AND DRUG ADMINISTRATION OF UNITED STATES IND
CLEARANCE FOR
HBM1022 CLINICAL TRIAL INITIATION
Further company coverage: 2142.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HBM Holdings
See all newsBrief: HBM Holdings Says NMPA Approves Batoclimab Injection For Generalized Myasthenia Gravis
HBM climbs on development of AI biology foundation model
Brief: HBM Holdings' Unit Develops World's First Language Model For Fully Human Heavy-Chain-Only Antibodies
Brief: Hbm Holdings Says Solstice Oncology Launches Series A Financing Round
HK-listed HBM climbs on initiating next phase of asthma drug study